13F GuideFiling Basics
What is SEC Form 13F? Ultimate Guide to Institutional Equity Filings
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
AlphaSMO Research GuideRead Guide
CIK: 0001524362
Total reported value
—
$233.7M
9 檔
86.2%
As reported in its official Q3 2024 Form 13F filing, Indaba Capital Management, L.P.'s tracked investment portfolio stood at $233.7M with 9 total positions.
In Q3 2024, Indaba Capital Management, L.P. displayed an active expansion posture, initiating 3 new positions and adding to 3 existing holdings, outstripping position reductions.
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | HP5A | Equity Commonwealth | Stock-Other | 40.02% | — | +74.07% | |
| 2 | ESPR 4 11-15-25Bond | Esperion Therapeutics | Bond | 13.70% | — | +3275.00% | |
| 3 | BAND 0.5 04-01-28Bond | Bandwidth Inc | Bond | 13.44% | — | -18.27% | |
| 4 | ONTF | On24 Inc | Stock-Other | 11.10% | — | — | |
| 5 | XMTR 1 02-01-27Bond | Xometry Inc | Bond | 7.94% | — | +22.54% | |
| 6 | AXDX 5 12-15-26Bond | Accelerate Diagnostics | Bond | 5.31% | — | — | |
| 7 | IRWD 1.5 06-15-26Bond | Ironwood Pharmaceuticals | Bond | 3.41% | — | — | |
| 8 | LAB 5.25 12-01-24Bond | Standard Biotools Inc | Bond | 3.27% | — | — | |
| 9 | INN 1.5 02-15-26Bond | Summit Hotel Properties | Bond | 1.82% | — | — |
| # | Ticker | Issuer | Weight Change | Shares Change | Action |
|---|---|---|---|---|---|
| 1 | ESPR 4 11-15-25Bond | Esperion Therapeutics | +13.1% | +3275.00% | Add |
| 2 | HP5A | Equity Commonwealth | +6.2% | +74.07% | Add |
| 3 | IRWD 1.5 06-15-26Bond | Ironwood Pharmaceuticals | +3.4% | NEW | New buy |
| 4 | LAB 5.25 12-01-24Bond | Standard Biotools Inc | +3.3% | NEW | New buy |
| 5 | INN 1.5 02-15-26Bond | Summit Hotel Properties | +1.8% | NEW | New buy |
| 6 | XMTR 1 02-01-27Bond | Xometry Inc | -0.7% | +22.54% | Add |
| 7 | AXDX 5 12-15-26Bond | Accelerate Diagnostics | -2.2% | — | Unchanged |
| 8 | ONTF | On24 Inc | -5.4% | — | Unchanged |
| 9 | BL | Blackline Inc | -9.1% | EXIT | Sold out |
| 10 | BAND 0.5 04-01-28Bond | Bandwidth Inc | -10.4% | -18.27% | Trim |
According to official SEC Form 13F filings, Indaba Capital Management, L.P. reported a total U.S. public equity portfolio value of $233.7M across 9 disclosed positions in Q3 2024.
Expert Analysis & Guides for Tracking Wall Street Smart Money Movements
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
In terms of portfolio concentration, the top 5 core holdings (including HP5A, ESPR 4 11-15-25, BAND 0.5 04-01-28) accounted for 86.2% of total reported equity market value during Q3 2024.
Top New Position Initiated
IRWD 1.5 06-15-26
市值: $8.0M
Top Position Liquidated / Trimmed
BL
前期市值: $14.1M
During Q3 2024, Indaba Capital Management, L.P.'s top holdings by market value included HP5A (40.0%)、ESPR 4 11-15-25 (13.7%)、BAND 0.5 04-01-28 (13.4%). The largest single position, HP5A, represented 40.0% of total portfolio value.
In Q3 2024, Indaba Capital Management, L.P. made 8 total portfolio adjustments, initiating 3 new buys, adding to 3 positions, trimming 1 holdings, and fully liquidating 1 stocks.
All holding records on this page are fetched directly from the U.S. Securities and Exchange Commission (SEC) EDGAR system (Form 13F-HR). AlphaSMO parses CUSIP identifiers and formats data into Schema.org-compliant datasets.
Understand SEC Form 4 insider disclosures for corporate officers, directors, and 10% owners to track executive transactions.
Understand Rule 144 restricted stock sale notices to spot planned insider liquidations before market sell pressure arrives.
Explore the 5% beneficial ownership threshold, 13D vs 13G filing differences, and recent SEC accelerated deadline rules.
Best practices for analyzing 13F quarterly changes without getting misled by stock splits, options, or market valuation drift.
Learn how AlphaSMO's flagship signal detects high-conviction stocks where 13F hedge funds and corporate insiders buy at the same time.